The OsteoFab is OPM’s brand name for device parts additively manufactured from PEKK polymer, according to the report. Implants created using the 3-D printing process can be specifically shaped to each patient’s anatomy. OsteoFab is one of the first additively manufactured polymer implants to receive FDA approval.
Patient specific implants, such as the OsteoFab, can assist in replacing skull voids due to trauma or disease.
More Articles on Devices:
Dr. Richard Kube Performs First Coflex Interlaminar Implant in Illinois
Sports Medicine Device Sales Increase Arthrocare’s 4Q Revenue by 4.9%
Dr. D. Kevin Lester Performs First US Knee Replacements With NavioPFS
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.